TDOC - Patience for optimal entry.Teladoc Health to Merge With Livongo to Improve Services
Teladoc Health, Inc. TDOC recently entered into a definitive merger agreement with Livongo Health, Inc. LVGO, which is an Applied Health Signals company. Subject to customary approval, the cash-stock transaction valued at $18.5 billion is likely to conclude by the end of fourth-quarter 2020.
Upon closure of the transaction, the existing shareholders of Teladoc Health and Livongo will own around 58% and 42%, respectively, of the combined company.
Benefits of the Deal
The merger of the companies, both of which already excel in virtual health and chronic condition management, will create a comprehensive virtual healthcare delivery system. This, in turn, will result in improved health outcomes and reduced costs across the healthcare ecosystem.
Moreover, the platform of the combined company will be equipped with AI+AI engine-driven “nudges”, health coaches, therapists, board-certified physicians and specialists. The platform will also provide consumers access to real-time information and demonstrate ways to manage their well-being.
TDOC
Queuing to see the Teladoc at 195Last night, Teladoc which has been going up for more than 200% since the beginning of 2020 has a sharp fall of nearly 16%.
It is highly likely that it will have a pull back tonight and I expect the price to head further south towards 195 price level before I take a long shot.
Read latest news here
See our calls in Feb and May 2020
TDOC - 11.24% Potential Profit - Ascending TriangleClear Uptrend Corridor with Support and Resistance confirmed multiple times over the past 2 months. Ascending Triangle formed within, breaking through consolidation.
I would place a limit entry order to confirm the new support.
- Historical uptrend
- RSI + Stoch well above 50
- MACD above Signal.
Suggested Entry $238.65
Suggested Stop Loss $232.37
Target price $265
4.16.2020 TDOC Bearish Divergence up to the Monthly TFCOVID has pumped this stock to overbought.
Teladoc Health now anticipates revenues for the first quarter of 2020 to be in the range of $180-181 million, up 40% year over year. Adjusted EBITDA is expected in the band of $10-11 million compared with $1.2 million in the first quarter of 2019.
-NFA
$TDOC Continues to Press the TrendTDOC continues to trend higher in an accelerating parabolic curve, with an Ichimoku Cloud trend indicator that is screaming for extension of that trend.
The consolidation in play now is a bullish symmetric triangle as volume mounts given the deregulation of the telehealth space to combat the coronavirus pandemic threat.
$TDOC Breakout Accelerates to Parabolic Fever PitchTDOC is off and running in a classic bullish range breakout and an acceleration of its ongoing upward trend into a parabolic mode as the specter of a hospital capacity crisis looms on the COVID-19 pandemic horizon. Telehealth regulations have been stripped to open the gates. And TDOC is positioned to thrive.
$TDOC Bull Flag - Unusual Options Activity$TDOC Bull Flag - Unusual Options Activity - Earnings today post close
Bullish options activity today - $1.7M earnings bet on 70.00/75.00 strike March calls. 8k traded vs OI of 1k
Near term target - $76.00
Note: Informational analysis, not investment advice.
TDOC - 618 Fib Retracement Entry on MACD Cross-over on weekly chTeledoc medical billing is crossing over the weekly MACD after recent drop. Entry point just over $63 on 618 Fibonacci Retracement.
Software + Medical billing.
Make own decisions and let me hear your opinion on this company. Total debt <$10 of Mkt Cap, no dividend, and healthcare through any mobile device.
Is TDOC a takeover target of AMZN?For all fundamental reasons the success of Teladoc is noble but you can see from this accumulation/distribution chart that someone is heavily accumulating the stock. There are multitude of reasons this could be happening. One super exciting and others very typical of trading in growth companies.
So let's start with my far flung idea. Amazon is pushing aggressively to get into the healthcare space. There was talks of Amazon buying a large insurance provider such as Aetna. A much more reasonable acquisition, and one that would be the perfect fit to stair-step them into the space is Teladoc. Teladoc conducts medical exams entirely online and over the phone. They boast almost 20 million customer accounts around the world and have an opportunity in the U.S. alone to do at least 75 times their current volume of consultations. What better place for people to find that than the Wal-mart of the online world. Amazon. For that matter if Wal-mart took notice they would also be a suitor.
Catalyst 2: Short interest. For a long time short traders were rooting for Teladoc to fail because they were spending heavy to acquire competitors and pushing growth over all else. Well those bets have not paid off at all. As a matter of fake with an estimated 38% of the float short we could see a short squeeze for the record books playing out before our eyes.
Catalyst 3: The future prospects for TDOC without it being sold. Even with no buyer TDOC has grown over 100% this year with their own internal marketing push and the acquisition of their second biggest competitor. They are insurmountably the leader of the pack in tele-medicine. They are the uber of doctors if you will. They are in the critical mass stage. Twenty million customers turns into 50 million real fast when people start to tell their friends how their doctors 'visit' fell from $160 to $40. There is no doubting it is a disruption of the mega status quo and several of those companies have gone on to be worth 60-100 billion dollars. That is a 30x-50x from today's 3.8 billion dollar value.
*** These opinions are my own and not meant to be financial advice. I am currently long TDOC calls.